We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+28.39%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.06B
AUM Growth
+$953M
Cap. Flow
+$556M
Cap. Flow %
10.99%
Top 10 Hldgs %
34.58%
Holding
150
New
52
Increased
21
Reduced
21
Closed
24

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$116M
2
ONCR
Oncorus, Inc.
ONCR
+$66M
3
TOI icon
The Oncology Institute
TOI
+$56.2M
4
CYTK icon
Cytokinetics
CYTK
+$45M
5
VTRS icon
Viatris
VTRS
+$40M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$196M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$142M
3
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$96M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$74.4M
5
DFPHU
DFP Healthcare Acquisitions Corp. Unit
DFPHU
+$58.3M

Sector Composition

Rank Sector Weight
1 Healthcare 69.84%
2 Industrials 0.55%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MOH icon
51
Molina Healthcare
MOH
$10.5B
$26.6M 0.53%
125,000
-28,000
-18% -$5.78M
ADVM
52
DELISTED
Adverum Biotechnologies
ADVM
$26.1M 0.52%
240,444
– –
BDTX icon
53
Black Diamond Therapeutics
BDTX
$101M
$25.7M 0.51%
802,511
– –
INZY
54
DELISTED
Inozyme Pharma
INZY
$23.7M 0.47%
1,150,299
– –
OSUR icon
55
OraSure Technologies
OSUR
$277M
$22.5M 0.44%
2,124,515
-36,468
-2% -$478K
MAACU
56
DELISTED
Montes Archimedes Acquisition Corp. Unit
MAACU
– –
0
– –
CERT icon
57
Certara
CERT
$1.23B
$20.2M 0.4%
+600,000
New +$22M
AMWL icon
58
American Well
AMWL
$185M
$20M 0.4%
39,556
– –
PRAX icon
59
Praxis Precision Medicines
PRAX
$8.25B
$19.3M 0.38%
+23,333
New +$13.6M
TARA icon
60
Protara Therapeutics
TARA
$221M
$18.9M 0.37%
782,670
– –
OXFD
61
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$18.3M 0.36%
1,049,035
+420,896
+67% +$5.9M
MDVL
62
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$17.2M 0.34%
+22,851
New +$16M
ALGS icon
63
Aligos Therapeutics
ALGS
$26.3M
$16.6M 0.33%
+24,000
New +$11.7M
ARDX icon
64
Ardelyx
ARDX
$1.25B
$16.6M 0.33%
2,561,554
– –
VAPO
65
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$16.2M 0.32%
+75,565
New +$16.9M
ALEC icon
66
Alector
ALEC
$169M
$16M 0.32%
1,055,192
-406,786
-28% -$5.06M
ITMR
67
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
$15.8M 0.31%
793,803
+294,667
+59% +$5.89M
AERI
68
DELISTED
Aerie Pharmaceuticals
AERI
$15.7M 0.31%
1,162,033
+667,817
+135% +$8.07M
SEM
69
DELISTED
Select Medical
SEM
$15.6M 0.31%
1,048,640
– –
PACB icon
70
Pacific Biosciences
PACB
$432M
$14.9M 0.29%
+575,000
New +$9.77M
ZBH icon
71
Zimmer Biomet
ZBH
$18.5B
$14.6M 0.29%
+97,850
New +$13.8M
BSX icon
72
Boston Scientific
BSX
$68.5B
– –
0
– –
CDAK
73
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$14.5M 0.29%
+450,000
New +$5.95M
SYK icon
74
Stryker
SYK
$133B
$14.5M 0.29%
+59,000
New +$13.4M
BMRN icon
75
BioMarin Pharmaceuticals
BMRN
$12B
$14.3M 0.28%
+163,000
New +$12.9M
1 2
3
4 5

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q4 2020 Portfolio in Review

As of Q4 2020, Deerfield Management held 150 positions worth $5.06B, up 23% from $4.11B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Deerfield Management deployed $556M of net new capital in Q4 2020, opening 52 new positions and adding to 21 existing holdings. Its largest new stake was Biogen: 448,000 shares worth $110M.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, up from 62% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was DFP Healthcare Acquisitions Corp. Unit, an estimated $58.3M trimmed.

  • Deerfield Management's largest Q4 2020 buy was Biogen: 448,000 shares worth $110M.
  • Deerfield Management added most to Viatris in Q4 2020, an estimated $40M increase.
  • Deerfield Management's biggest Q4 2020 reduction was DFP Healthcare Acquisitions Corp. Unit, cutting an estimated $58.3M.
  • Deerfield Management fully exited Immunomedics Inc in Q4 2020, selling an estimated $196M.
  • Deerfield Management's ten largest holdings make up 35% of its $5.06B portfolio in Q4 2020.
  • Deerfield Management opened 52 new positions and closed 24 in Q4 2020.
  • Deerfield Management's portfolio value rose 23% quarter-over-quarter to $5.06B.

Based on Deerfield Management's 13F filing for Q4 2020, filed 16 Feb 2021.